Skip to main content

Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

Feedback
Newsletter
RSS
Twitter

User Top Menu

Welcome, guest
Log In
Join
Why Join?

Search form

Search

About Us
- Overview
- Who We Are
- Contact
- Fan Mail
- How to Cite
News & Future Directions
Papers
Forums
- Discussions
- Webinars
Professional Resources
Research Resources
Click Here to Support MSDF

You are here

Most Viewed

Coping with multiple sclerosis-the role of social support.
Measuring Brain Tissue Integrity during 4 Years Using Diffusion Tensor Imaging.
Which gait parameter can be used to evaluate gait improvement in multiple sclerosis?
Design of a strong cation exchange methodology for the evaluation of charge heterogeneity in glatiramer acetate.
Case-Control Studies Are Not Familial Studies.
Listeria rhombencephalitis mimicking a demyelinating event in an immunocompetent young patient.
Ionotropic glutamate receptor expression in human white matter.
Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis.
Utilization of Dimethyl Fumarate and Related Molecules for Treatment of Multiple Sclerosis, Cancer, and Other Diseases.
Forced exercise increases muscle mass in EAE despite early onset of disability.
Assessing Four Quality Indicators for Multiple Sclerosis Management Through Patient-Reported Data.
Pediatric multiple sclerosis: Conventional first-line treatment and general management.
Stressful life events and the risk of initial central nervous system demyelination.
Transverse Myelitis and Neuromyelitis Optica Spectrum Disorders.
Publicly Available Data Provide Evidence against NR1H3 R415Q Causing Multiple Sclerosis.
Cognitive reserve in multiple sclerosis.
Fingolimod-induced leukoencephalopathy in a patient with neuromyelitis optica spectrum disorder.
Disability progression in aggressive multiple sclerosis.
Brain atrophy measurements should be used to guide therapy monitoring in MS - Commentary.
Assessment of vitamin D status - a changing landscape.
Antibodies in multiple sclerosis oligoclonal bands target debris.
Validation of the Oxford Participation and Activities Questionnaire.
Stem Cells Therapy in Multiple Sclerosis - A New Hope for Progressive Forms.
Mobitz type I and II atrioventricular blocks during fingolimod therapy.
Difference-in-Differences Method in Comparative Effectiveness Research: Utility with Unbalanced Groups.

Pages

« first
‹ previous
…
810
811
812
813
814
815
816
817
818
…
next ›
last »

MSDF Footer

Copyright © 2014 MGH and ACP

Privacy
Terms of Use
How to Cite
FAQ/Help
Site Map
Support Us
Feedback
Image Credits

All site content, except where otherwise noted, is licensed under a Creative Commons BY license. Please let us know where and how you use MSDF material.

Content By

Software By